Dynamic PET/CT imaging of 18 F-(2 S , 4 R )4-fluoroglutamine in healthy volunteers and oncological patients
Conclusions18F-FGln images may further supplement the diagnostic ability of18F-FDG in cancer patients and detect metabolic changes in different tumors. Furthermore, the imaging time for18F-FGln PET/CT needs to be optimized for different cancer types to improve the contrast resolution of tumors.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | CT Scan | Heart | Lung Cancer | Nuclear Medicine | PET Scan | Study | Thyroid | Thyroid Cancer